Song Ruilin, executive chairman, and Liu Dianbo, vice chairman, met with former Minister of health, labor and welfare, member of the parliament of Erlang Kawasaki

Source: on the afternoon of April 6, 2017 local time, song Ruilin, executive chairman of China Pharmaceutical Innovation Promotion Association (hereinafter referred to as "China pharmaceutical promotion association"), Liu Dianbo, vice chairman of China pharmaceutical promotion association and chairman of the board of directors of green leaf Pharmaceutical Group, met with senior congressman of the Japanese Liberal Democratic Party and former Minister of health, labor and welfare of Erlang Kawasaki in Tokyo Kawasaki Erlang was first elected as a member of Parliament in 1980, and has been reelected for 11 times He has successively held important positions such as Minister of transport (1998), chairman of the house of Representatives (2004), Minister of health and labor (2005), and is an authoritative expert in the field of pharmaceutical policy and industrial development in Japan At the meeting, Congressman Kawasaki Erlang welcomed the delegation of China Council for the promotion of drugs, and introduced the current medical insurance system, the development of the pharmaceutical industry and the incentive policies for pharmaceutical innovation in Japan to the delegation President Song Ruilin introduced China's current situation in the above fields, and exchanged in-depth views on the policy balance between pharmaceutical innovation and medical insurance finance, and the establishment of more effective cooperation between China and Japan in the field of pharmaceutical innovation Vice president Liu Dianbo expressed the concern of China's international pharmaceutical innovation enterprises represented by green leaf Pharmaceutical Group on Japan's pharmaceutical policy and industrial development The two sides agreed that China and Japan have a wide range of cooperation space in the field of medicine and should earnestly deepen exchanges and enhance trust, and make further breakthroughs in promoting mutual responsibility, industrial investment and policy exchanges Jiang Hua, vice president of green leaf Pharmaceutical Group, Jin Jie, general manager of Japan branch, and Wang Yuanyuan and Yuan Yuan Yuan of China pharmaceutical promotion association attended the meeting Group photo of participants and Congressman Kawasaki Erlang (second from left)